PIRS Pieris Pharmaceuticals Inc.

3.11
+0.04  (+1%)
Previous Close 3.07
Open 3.08
Price To Book 3.34
Market Cap 168405626
Shares 54,149,719
Volume 152,868
Short Ratio
Av. Daily Volume 509,367

SEC filingsSee all SEC filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19604988
  2. 8-K - Current report 19563767
  3. 8-K - Current report 19512160
  4. 8-K - Current report 181191277
  5. 8-K - Current report 181186067

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2a data due 1H 2019.
PRS-080
Anemia of chronic disease
Phase 1 initial data due at upcoming meeting.
PRS-060
Healthy subjects
Phase 1 data due 1H 2019.
PRS-343
HER2-positive solid tumors
Phase 1 data due 2019.
PRS-343 and atezolizumab (Tecentriq)
HER2-positive solid tumors

SEC Filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19604988
  2. 8-K - Current report 19563767
  3. 8-K - Current report 19512160
  4. 8-K - Current report 181191277
  5. 8-K - Current report 181186067
  6. 8-K - Current report 181172108
  7. 10-Q - Quarterly report [Sections 13 or 15(d)] 181166265
  8. 8-K - Current report 181164710
  9. 8-K - Current report 181147371
  10. 8-K - Current report 181137717